Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased the frequency and broadened the spectrum of lung toxicity, particularly in patients with cancer. The diagnosis of drug-related pneumonitis (DRP) is usually achieved by excluding other potential known causes. Awar...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
12 January 2021
|
| In: |
Chest
Year: 2021, Volume: 159, Issue: 3, Pages: 1107-1125 |
| ISSN: | 1931-3543 |
| DOI: | 10.1016/j.chest.2020.11.027 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.chest.2020.11.027 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0012369220353137 
|
| Author Notes: | Takeshi Johkoh, MD, PhD; Kyung Soo Lee, MD, PhD; Mizuki Nishino, MD, MPH; William D. Travis, MD; Jay H. Ryu, MD; Ho Yun Lee, MD, PhD; Christopher J. Ryerson, MD, MAS; Tomás Franquet, MD, PhD; Alexander A. Bankier, MD, PhD; Kevin K. Brown, MD; Jin Mo Goo, MD, PhD; Hans-Ulrich Kauczor, MD; David A. Lynch, MB; Andrew G. Nicholson, MD; Luca Richeldi, MD, PhD; Cornelia M. Schaefer-Prokop, MD, PhD; Johny Verschakelen, MD, PhD; Suhail Raoof, MD; Geoffrey D. Rubin, MD, MBA; Charles Powell, MD; Yoshikazu Inoue, MD, PhD; and Hiroto Hatabu, MD, PhD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1757718036 | ||
| 003 | DE-627 | ||
| 005 | 20241230014044.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210512s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.chest.2020.11.027 |2 doi | |
| 035 | |a (DE-627)1757718036 | ||
| 035 | |a (DE-599)KXP1757718036 | ||
| 035 | |a (OCoLC)1341408819 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Johkoh, Takeshi |e VerfasserIn |0 (DE-588)1235833895 |0 (DE-627)1760991708 |4 aut | |
| 245 | 1 | 0 | |a Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors |b a position paper from the Fleischner Society |c Takeshi Johkoh, MD, PhD; Kyung Soo Lee, MD, PhD; Mizuki Nishino, MD, MPH; William D. Travis, MD; Jay H. Ryu, MD; Ho Yun Lee, MD, PhD; Christopher J. Ryerson, MD, MAS; Tomás Franquet, MD, PhD; Alexander A. Bankier, MD, PhD; Kevin K. Brown, MD; Jin Mo Goo, MD, PhD; Hans-Ulrich Kauczor, MD; David A. Lynch, MB; Andrew G. Nicholson, MD; Luca Richeldi, MD, PhD; Cornelia M. Schaefer-Prokop, MD, PhD; Johny Verschakelen, MD, PhD; Suhail Raoof, MD; Geoffrey D. Rubin, MD, MBA; Charles Powell, MD; Yoshikazu Inoue, MD, PhD; and Hiroto Hatabu, MD, PhD |
| 264 | 1 | |c 12 January 2021 | |
| 300 | |a 19 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.05.2021 | ||
| 520 | |a Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased the frequency and broadened the spectrum of lung toxicity, particularly in patients with cancer. The diagnosis of drug-related pneumonitis (DRP) is usually achieved by excluding other potential known causes. Awareness of the incidence and risk factors for DRP is becoming increasingly important. The severity of symptoms associated with DRP may range from mild or none to life-threatening with rapid progression to death. Imaging features of DRP should be assessed in consideration of the distribution of lung parenchymal abnormalities (radiologic pattern approach). The CT patterns reflect acute (diffuse alveolar damage) interstitial pneumonia and transient (simple pulmonary eosinophilia) lung abnormality, subacute interstitial disease (organizing pneumonia and hypersensitivity pneumonitis), and chronic interstitial disease (nonspecific interstitial pneumonia). A single drug can be associated with multiple radiologic patterns. Treatment of a patient suspected of having DRP generally consists of drug discontinuation, immunosuppressive therapy, or both, along with supportive measures eventually including supplemental oxygen and intensive care. In this position paper, the authors provide diagnostic criteria and management recommendations for DRP that should be of interest to radiologists, clinicians, clinical trialists, and trial sponsors, among others. | ||
| 700 | 1 | |8 1\p |a Lee, Kyung Soo |e VerfasserIn |0 (DE-588)1046375059 |0 (DE-627)776189638 |0 (DE-576)399691111 |4 aut | |
| 700 | 1 | |a Nishino, Mizuki |e VerfasserIn |4 aut | |
| 700 | 1 | |8 2\p |a Travis, William D. |d 1955- |e VerfasserIn |0 (DE-588)12436781X |0 (DE-627)085816302 |0 (DE-576)294139958 |4 aut | |
| 700 | 1 | |a Ryu, Jay H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lee, Ho Yun |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ryerson, Christopher J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Franquet, Tomás |e VerfasserIn |4 aut | |
| 700 | 1 | |8 3\p |a Bankier, Alexander |e VerfasserIn |0 (DE-588)173618316 |0 (DE-627)698527917 |0 (DE-576)134461401 |4 aut | |
| 700 | 1 | |a Brown, Kevin K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goo, Jin Mo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kauczor, Hans-Ulrich |d 1962- |e VerfasserIn |0 (DE-588)139267123 |0 (DE-627)70327113X |0 (DE-576)310955327 |4 aut | |
| 700 | 1 | |8 4\p |a Lynch, David A. |d 1956- |e VerfasserIn |0 (DE-588)1074128427 |0 (DE-627)830280731 |0 (DE-576)437520110 |4 aut | |
| 700 | 1 | |a Nicholson, Andrew |e VerfasserIn |0 (DE-588)1161562052 |0 (DE-627)1024846725 |0 (DE-576)506733912 |4 aut | |
| 700 | 1 | |8 5\p |a Richeldi, Luca |e VerfasserIn |0 (DE-588)116026578X |0 (DE-627)1023418843 |0 (DE-576)505817535 |4 aut | |
| 700 | 1 | |a Schaefer-Prokop, Cornelia M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Verschakelen, Johny |e VerfasserIn |4 aut | |
| 700 | 1 | |8 6\p |a Raoof, Suhail |d 1961- |e VerfasserIn |0 (DE-588)1146232241 |0 (DE-627)100777794X |0 (DE-576)181985306 |4 aut | |
| 700 | 1 | |8 7\p |a Rubin, Geoffrey D. |e VerfasserIn |0 (DE-588)1216660166 |0 (DE-627)1727910125 |4 aut | |
| 700 | 1 | |a Powell, Charles |e VerfasserIn |4 aut | |
| 700 | 1 | |a Inoue, Yoshikazu |e VerfasserIn |4 aut | |
| 700 | 1 | |8 8\p |a Hatabu, Hiroto |e VerfasserIn |0 (DE-588)1223100146 |0 (DE-627)1742411517 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chest |d Amsterdam : Elsevier, 1935 |g 159(2021), 3, Seite 1107-1125 |h Online-Ressource |w (DE-627)320460819 |w (DE-600)2007244-2 |w (DE-576)09089202X |x 1931-3543 |7 nnas |a Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors a position paper from the Fleischner Society |
| 773 | 1 | 8 | |g volume:159 |g year:2021 |g number:3 |g pages:1107-1125 |g extent:19 |a Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors a position paper from the Fleischner Society |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.chest.2020.11.027 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0012369220353137 |x Verlag |z lizenzpflichtig |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 2\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 3\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 4\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 5\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 6\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 7\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 8\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20210512 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 139267123 |a Kauczor, Hans-Ulrich |m 139267123:Kauczor, Hans-Ulrich |d 910000 |d 911400 |e 910000PK139267123 |e 911400PK139267123 |k 0/910000/ |k 1/910000/911400/ |p 12 | ||
| 999 | |a KXP-PPN1757718036 |e 3927644714 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Johkoh, Takeshi","role":"aut","given":"Takeshi","family":"Johkoh"},{"role":"aut","display":"Lee, Kyung Soo","given":"Kyung Soo","family":"Lee"},{"given":"Mizuki","family":"Nishino","role":"aut","display":"Nishino, Mizuki"},{"display":"Travis, William D.","role":"aut","given":"William D.","family":"Travis"},{"family":"Ryu","given":"Jay H.","role":"aut","display":"Ryu, Jay H."},{"role":"aut","display":"Lee, Ho Yun","family":"Lee","given":"Ho Yun"},{"role":"aut","display":"Ryerson, Christopher J.","given":"Christopher J.","family":"Ryerson"},{"given":"Tomás","family":"Franquet","role":"aut","display":"Franquet, Tomás"},{"display":"Bankier, Alexander","role":"aut","family":"Bankier","given":"Alexander"},{"family":"Brown","given":"Kevin K.","role":"aut","display":"Brown, Kevin K."},{"family":"Goo","given":"Jin Mo","role":"aut","display":"Goo, Jin Mo"},{"display":"Kauczor, Hans-Ulrich","role":"aut","given":"Hans-Ulrich","family":"Kauczor"},{"family":"Lynch","given":"David A.","role":"aut","display":"Lynch, David A."},{"family":"Nicholson","given":"Andrew","role":"aut","display":"Nicholson, Andrew"},{"role":"aut","display":"Richeldi, Luca","family":"Richeldi","given":"Luca"},{"family":"Schaefer-Prokop","given":"Cornelia M.","display":"Schaefer-Prokop, Cornelia M.","role":"aut"},{"role":"aut","display":"Verschakelen, Johny","family":"Verschakelen","given":"Johny"},{"family":"Raoof","given":"Suhail","role":"aut","display":"Raoof, Suhail"},{"given":"Geoffrey D.","family":"Rubin","display":"Rubin, Geoffrey D.","role":"aut"},{"role":"aut","display":"Powell, Charles","family":"Powell","given":"Charles"},{"role":"aut","display":"Inoue, Yoshikazu","family":"Inoue","given":"Yoshikazu"},{"family":"Hatabu","given":"Hiroto","display":"Hatabu, Hiroto","role":"aut"}],"title":[{"subtitle":"a position paper from the Fleischner Society","title_sort":"Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors","title":"Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors"}],"relHost":[{"origin":[{"publisherPlace":"Amsterdam ; Northbrook, Ill. [u.a.]","dateIssuedKey":"1935","publisher":"Elsevier ; American College of Chest Physicians","dateIssuedDisp":"1935-"}],"note":["Gesehen am 09.11.2017"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"320460819","id":{"issn":["1931-3543"],"eki":["320460819"],"zdb":["2007244-2"]},"pubHistory":["1.1935 -"],"corporate":[{"display":"American College of Chest Physicians","role":"isb"}],"part":{"text":"159(2021), 3, Seite 1107-1125","pages":"1107-1125","issue":"3","year":"2021","volume":"159","extent":"19"},"title":[{"title":"Chest","title_sort":"Chest","subtitle":"official publication of the American College of Chest Physicians ; for specialists in pulmonology, critical care, sleep medicine, thoracic surgery, cardiorespiratory interactions and related disciplines"}],"language":["eng"],"disp":"Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors a position paper from the Fleischner SocietyChest","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"Diseases of the chest"},{"title":"for pulmonologists, cardiologists, cardiothoracic surgeons, critical care physicians, and related specialists"},{"title":"the cardiopulmonary and critical care journal"},{"title":"for pulmonologists, cardiologists, cardiothoracic surgeons, critical care physicians, and related specialists"}]}],"physDesc":[{"extent":"19 S."}],"note":["Gesehen am 12.05.2021"],"origin":[{"dateIssuedDisp":"12 January 2021","dateIssuedKey":"2021"}],"id":{"eki":["1757718036"],"doi":["10.1016/j.chest.2020.11.027"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Takeshi Johkoh, MD, PhD; Kyung Soo Lee, MD, PhD; Mizuki Nishino, MD, MPH; William D. Travis, MD; Jay H. Ryu, MD; Ho Yun Lee, MD, PhD; Christopher J. Ryerson, MD, MAS; Tomás Franquet, MD, PhD; Alexander A. Bankier, MD, PhD; Kevin K. Brown, MD; Jin Mo Goo, MD, PhD; Hans-Ulrich Kauczor, MD; David A. Lynch, MB; Andrew G. Nicholson, MD; Luca Richeldi, MD, PhD; Cornelia M. Schaefer-Prokop, MD, PhD; Johny Verschakelen, MD, PhD; Suhail Raoof, MD; Geoffrey D. Rubin, MD, MBA; Charles Powell, MD; Yoshikazu Inoue, MD, PhD; and Hiroto Hatabu, MD, PhD"]},"language":["eng"],"recId":"1757718036"} | ||
| SRT | |a JOHKOHTAKECHESTCTDIA1220 | ||